We asked for your predictions for 2017, and you delivered. Here’s what you’re expecting in the coming year. (Responses are lightly edited for length and clarity.)
More recognition of addiction as a disease
In 2017, we expect there to be increasing recognition of addiction as a disease requiring medical treatment, and better reimbursement for pharmacotherapy.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
